Jonathan Friedland

Jonathan Friedland
FRCP FRCPE FRCPI FMedSci
Born
Jonathan Samuel Friedland

London
Alma materUniversity of Cambridge
King's College Hospital
Scientific career
FieldsInfectious diseases
WorkplacesSt George's, University of London
Imperial College London

Jonathan Samuel Friedland FRCP FRCPE FRCPI FMedSci is a British physician and medical researcher. As of June 2026 he is professor of infectious diseases at City St George's, University of London, and since April 2026 has served as president of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID).

Early life and education

Jonathan Samuel Friedland,[1] the son of Albert and Rosalind Friedland, was born in London.

Friedland earned a BA and MA at the University of Cambridge and a medical degree (MBBS) and a PhD at the University of London. He also studied medicine at and King's College Hospital. He completed his junior medical training at the Royal Brompton Hospital, the Royal Postgraduate Medical School, and the John Radcliffe Hospital in Oxford.[2]

Friedland later undertook a Clinical Research Fellowship funded by the Medical Research Council at St George's, University of London.[2]

Career

Academia

Friedland was appointed senior lecturer at the Royal Postgraduate Medical School and honorary consultant in infectious disease at the Hammersmith Hospital.

In 2004, he became professor of infectious diseases and head of infectious diseases and immunity at the Royal Postgraduate Medical School, later Imperial College London. He served as Director (formerly Dean) of the Hammersmith campus, Imperial College London, from 2010. Friedland maintained an active clinical practice as honorary consultant in infectious diseases and Medicine, Imperial College Healthcare (formerly Hammersmith Hospitals) NHS Trust, from 1994 to 2018, and served as chief of clinical service from 2004 to 2013.

In 2018, Friedland joined St George's, University of London as Deputy Vice-Chancellor (research and enterprise) and Professor of Infectious Diseases. Following the merger of City and St George’s, University of London, he became Vice-President (research & innovation).[2]

Regulatory and advisory roles

Friedland has held numerous regulatory and advisory positions. He is a non-executive board member of the UK Health Security Agency (2022–), where he chairs the Science & Research Committee and sits on the Audit & Risk Committee.[3]

He chaired the MHRA Expert Working Group on COVID-19 Therapeutics from 2020 to 2023[4] and served as Vice-Chair of the Commission on Human Medicines (2014–22). Friedland also chaired the MHRA Expert Advisory Group on Infection from 2015 to 2022.[5]

During the COVID-19 pandemic, he was a member of the COVID-19 Vaccine Safety Surveillance Methodologies Expert Working Group.[6] He had previously served on the Joint Committee on Vaccination and Immunisation[7] and, from 2007 to 2012,[2] on the National Expert Panel on New and Emerging Infections (NEPNEI), which was established in 2003 "to provide independent expert advice to the England Chief Medical Officer (CMO) on the public health risk from new and emerging infections".[8]

Other memberships and roles

Friedland was president of the British Infection Association from 2007 to 2009.[2]

In 2020, he was elected to the executive committee of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), initially taking up the role of scientific affairs secretary.[9] He has held various other roles within ESCMID, including serving on the programme committee of ESCMID Global, the largest infection conference in the world. In 2024, he was appointed ESCMID secretary general and president-elect. In April 2026 he was appointed president of ESCMID.[10][11][12]

Research

Friedland's research is focused on innate immune responses and particularly the role of matrix metalloproteinases in the immunopathology of tuberculosis and the development of host-directed therapy. He also has long-standing research interests in migrant health as well as in new TB diagnostics. Friedland has published over 250 peer reviewed papers, invited editorials and reviews as well as three books.[13]

He was a member of the Medical Research Council Clinical Training and Career Development Panel from 2009 to 2013.[14]

Awards

In 2005 his research team won the Medical Futures Innovations Award for best overall innovation.[15]

In 2005, Friedland was awarded the Royal College of Physicians' Weber-Parkes Prize Medal for research in tuberculosis.[2]

He was elected Fellow of the Academy of Medical Sciences in 2008[16] and a Fellow of the Royal College of Physicians of Ireland in 2010. In 2017, he was awarded an inaugural Fellowship of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID).[17]

Chess

Friedland enjoys playing chess.[18] Friedland was the Cambridge University Chess Champion, and represented Cambridge in the 97th-99th Varsity Chess Matches. He was awarded 'Best Cambridge Game' for his match in the 98th.[19] In 2004 Friedland achieved the title of Candidate Master (CM)[20] and won the Chess Blitz Championship Gold Medal in the 2018 Mind Sports Olympiad.[21]

References

  1. ↑ "Friedland, Prof. Jonathan Samuel". Who's Who. Oxford University Press. 2017. doi:10.1093/ww/9780199540884.013.U249893. Professor of Infectious Diseases and Head, Infectious Diseases and Immunity, since 2004, and Director (formerly Dean), Hammersmith campus, since 2010, Imperial College London; Honorary Consultant in Infectious Diseases and Medicine, Imperial College Healthcare (formerly Hammersmith Hospitals) NHS Trust, since 1994
  2. 1 2 3 4 5 6 "Professor Jon Friedland". City St George's, University of London. 16 January 2025. Archived from the original on 9 June 2026. Retrieved 9 June 2026.
  3. ↑ "Our Governance". UK Government. Retrieved 26 January 2025.
  4. ↑ "COVID-19 Therapeutics Expert Working Group". UK Government. Retrieved 23 April 2021.
  5. ↑ "Commission on Human Medicines (CHM) Commissioners". UK Government. Retrieved 23 July 2018.
  6. ↑ "Membership and minutes for the Commission on Human Medicines (CHM) and its expert advisory groups (EAGs)". UK Government. Retrieved 23 April 2021.
  7. ↑ Joint Committee on Vaccination and Immunisation (JCVI) (May 2009). "Biennial Report 2007–2008" (PDF).
  8. ↑ "National Expert Panel on New and Emerging Infections: 2008 Annual Report" (PDF). UK Government. 2008. Retrieved 23 July 2018.
  9. ↑ "ESCMID membership". ESCMID. Archived from the original on 7 December 2021. Retrieved 23 November 2021.
  10. ↑ Kluytmans, Jan (21 April 2026). "Last night at the ESCMID Assembly of Members we inaugurated our new president, Jon S. Friedland. We extend our thanks to Robert Skov for his years of service and look forward to his new role as past…". LinkedIn. Retrieved 9 June 2026.
  11. ↑ "Professor Jon Friedland". City St George's, University of London. 16 January 2025. Retrieved 9 June 2026.
  12. ↑ "About us". ESCMID. Archived from the original on 9 June 2026. Retrieved 9 June 2026.
  13. ↑ "Jonathan Friedland curriculum vitae". Imperial College London. Retrieved 9 June 2026.
  14. ↑ "Jonathan Friedland curriculum vitae" (PDF). European Medicines Agency. Archived from the original (PDF) on 23 July 2018. Retrieved 15 July 2018.
  15. ↑ "New TB test scoops top prize at Medical Futures competition". Imperial College London. Retrieved 15 July 2018.
  16. ↑ "Professor Jonathan Friedland | The Academy of Medical Sciences". acmedsci.ac.uk. Retrieved 15 July 2018.
  17. ↑ "ESCMID Fellows - honorary ESCMID title for members". European Society of Clinical Microbiology and Infectious Diseases. Retrieved 15 July 2018.
  18. ↑ "The Lancet Dissecting Room: Jon Friedland". The Lancet. 355 (9204): 666. 19 February 2000. doi:10.1016/S0140-6736(05)72414-4. S2CID 53301595. Retrieved 5 August 2018.
  19. ↑ "BritBase". Retrieved 5 August 2018.
  20. ↑ Di Felice, Gino (2017). Chess International Titleholders, 1950-2016. McFarland Press. p. 376. ISBN 9781476671321.
  21. ↑ "Mind Sports Olympiad Results". Archived from the original on 20 August 2018. Retrieved 27 August 2018.
This page is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.